Bioengineering and Biotechnology in Liver Diseases : NIDDK

Bioengineering and Biotechnology in Liver Diseases

To develop ways to improve the detection and characterization of liver and biliary disease and to aid in targeting therapies to these sites.

For more information, please see the Action Plan for Liver Diseases Research, or contact Dr. Jose Serrano, Director of the Liver and Biliary Program.

Dr. Beena Akolkar, Immunopathogenesis and Genetics of Type 1 Diabetes Program Director
Dr. Terry Bishop, Hematology Research Programs Director
Dr. Olivier Blondel, Director, Endocrine Systems Biology Program
Dr. Edward Doo, Director of the Liver Diseases Program
Dr. Judith Fradkin, Director, Division of Diabetes, Endocrinology, and Metabolic Diseases
Dr. Catherine McKeon, Senior Advisor for Genetic Research in Diabetes, Endocrinology and Metabolic Diseases
Dr. Rebekah Rasooly, Deputy Director of the Division of Kidney, Urologic, and Hematologic Diseases
Dr. Jose Serrano, Director of the Liver and Biliary Program; Director of the Pancreas Program
Dr. Daniel Wright, Hematology Research Programs Director

* Documents in PDF format require the free Adobe Acrobat Reader

application for viewing.

Page last updated: November 05, 2010